HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ugur Ozerdem Selected Research

SHP099

10/2018SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ugur Ozerdem Research Topics

Disease

12Neoplasms (Cancer)
10/2019 - 02/2002
5Corneal Neovascularization
04/2013 - 01/2004
4Noninfiltrating Intraductal Carcinoma (DCIS)
12/2019 - 09/2014
3Breast Neoplasms (Breast Cancer)
01/2021 - 10/2019
3Necrosis
10/2019 - 02/2002
2Uveal melanoma
01/2006 - 02/2002
1Intraductal Papilloma
01/2021
1Autoimmune Diseases (Autoimmune Disease)
12/2019
1Breast Carcinoma In Situ
12/2019
1Amyloidosis
12/2019
1Diabetes Mellitus
12/2019
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2019
1Ovarian Neoplasms (Ovarian Cancer)
10/2018
1Triple Negative Breast Neoplasms
10/2018
1Mammary Paget's Disease
04/2016
1Carcinoma (Carcinomatosis)
11/2014
1Phyllodes Tumor (Cystosarcoma Phylloides)
04/2014
1Diabetic Retinopathy (Retinopathy, Diabetic)
03/2009
1Inflammation (Inflammations)
03/2009
1Type 2 Diabetes Mellitus (MODY)
09/2008
1Melanoma (Melanoma, Malignant)
07/2005
1Ischemia
01/2004
1Pathologic Neovascularization
01/2004
1Neurofibrosarcoma (MPNST)
01/2004
1Acquired Immunodeficiency Syndrome (AIDS)
10/2003
1Uveitis
10/2003
1Cytomegalovirus Retinitis
10/2003
1Choroidal Effusions
02/2002

Drug/Important Bio-Agent (IBA)

4chondroitin sulfate proteoglycan 4IBA
01/2006 - 01/2004
3Retinaldehyde (Retinal)IBA
03/2009 - 01/2004
2Proteoglycans (Proteoglycan)IBA
04/2013 - 01/2006
2Neutralizing AntibodiesIBA
02/2006 - 01/2004
2Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2006 - 02/2002
1Inosine Diphosphate (IDP)IBA
01/2021
1AndrogensIBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
12/2019
1Congo RedIBA
12/2019
1Insulin (Novolin)FDA Link
12/2019
1Prealbumin (Transthyretin)IBA
12/2019
1Proteins (Proteins, Gene)FDA Link
12/2019
1Estrogen ReceptorsIBA
10/2019
1LigandsIBA
10/2018
1trametinibIBA
10/2018
1tyrosine receptor (receptor, tyrosine)IBA
10/2018
1SHP099IBA
10/2018
1Phosphotransferases (Kinase)IBA
10/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2018
1Keratins (Keratin)IBA
04/2016
1CalponinsIBA
01/2015
1AlloMaxIBA
04/2014
1Acetylcysteine (Siran)FDA LinkGeneric
03/2009
1Free RadicalsIBA
03/2009
1Superoxide DismutaseIBA
03/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009
1Free Radical ScavengersIBA
03/2009
18-epi-prostaglandin F2alphaIBA
03/2009
1Islet Amyloid PolypeptideIBA
09/2008
1AntigensIBA
01/2006
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
10/2005
1Polyurethanes (Polyurethane)IBA
07/2005
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2004
1CytokinesIBA
10/2004
1E 10 (E-10)IBA
01/2004
1PolymersIBA
01/2004
1Immunoglobulins (Immunoglobulin)IBA
01/2004
1Cidofovir (Vistide)FDA Link
10/2003
1fluorescein isothiocyanate dextranIBA
01/2003
1PlasticsIBA
11/2002
1Matrix Metalloproteinases (MMPs)IBA
02/2002
1prinomastat (Ag3340)IBA
02/2002

Therapy/Procedure

4Therapeutics
01/2020 - 10/2003
2Segmental Mastectomy (Lumpectomy)
10/2019 - 09/2014
1Neoadjuvant Therapy
11/2014
1Mastectomy (Mammectomy)
04/2014
1Breast Implants (Breast Implant)
04/2014
1Lasers (Laser)
10/2005
1Catheters
07/2005
1Heterologous Transplantation (Xenotransplantation)
01/2004
1Highly Active Antiretroviral Therapy (HAART)
10/2003
1Transplantation
01/2003